Lluís Ribas de Pouplana
Corporate Officer/Principal bei ICREA
Profil
Lluís Ribas de Pouplana was the founder of Omnia Molecular SL, which was founded in 2005, where he held the title of Chief Scientific Officer.
Currently, he is a Professor at ICREA.
In the past, he worked as an Assistant Professor-Molecular Biology at The Scripps Research Institute from 1997 to 2003, and as a Principal at Massachusetts Institute of Technology from 1993 to 1997.
Dr. Ribas de Pouplana received his doctorate degree from The University of Edinburgh and his undergraduate degree from the University of Barcelona.
Aktive Positionen von Lluís Ribas de Pouplana
| Unternehmen | Position | Beginn |
|---|---|---|
| ICREA | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Lluís Ribas de Pouplana
| Unternehmen | Position | Ende |
|---|---|---|
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | Corporate Officer/Principal | - |
| Massachusetts Institute of Technology | Corporate Officer/Principal | 01.01.1997 |
Omnia Molecular SL
 Omnia Molecular SL Pharmaceuticals: MajorHealth Technology Omnia Molecular SL engaged in the designing of anti-infective pharmaceuticals. The firm used its proprietary platform to synthesize and develop novel drugs targeted at infections such as mycosis and tuberculosis. The company was founded by Lluís Ribas de Pouplana and Juan Gargallo Costa in 2005 and was headquartered in Barcelona, Spain. | Gründer | - |
Ausbildung von Lluís Ribas de Pouplana
| The University of Edinburgh | Doctorate Degree |
| University of Barcelona | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Omnia Molecular SL
Omnia Molecular SL Pharmaceuticals: MajorHealth Technology Omnia Molecular SL engaged in the designing of anti-infective pharmaceuticals. The firm used its proprietary platform to synthesize and develop novel drugs targeted at infections such as mycosis and tuberculosis. The company was founded by Lluís Ribas de Pouplana and Juan Gargallo Costa in 2005 and was headquartered in Barcelona, Spain. | Health Technology |
